Platinum and Polyadenosine 5'Diphosphoribose Polymerisation Inhibitor for Neoadjuvant Treatment of Triple Negative Breast Cancer and/or Germline BRCA Positive Breast Cancer
Clinical trial NCT03150576 · RECRUITING
Trial details
- NCT number
- NCT03150576
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2024-06-01
- Enrollment
- 780
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.